Related Experiment Video
Updated: Sep 16, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
Published on: March 28, 2025
Potential Catastrophic Health Expenditure Related to Treatment Cost for Families of Children With Orofacial Cleft in
Adegbayi Adeola Adekunle1, Abdul-Kabir Adegoke Yahya-Imam2, Olawale Olatubosun Adamson1
1Department of Oral and Maxillofacial Surgery, College of Medicine, University of Lagos/Lagos University Teaching Hospital, Lagos, Nigeria.
Abstract:
ObjectiveTo investigate the likelihood of families with a child with orofacial cleft falling into catastrophic healthcare expenditure (CHE) due to financial burden of caring for the child.DesignCross-sectional descriptive study using a 35-item interviewer administered proforma.SettingA tertiary health institution in Lagos, Nigeria.ParticipantsAll consenting caregivers attending the orofacial cleft clinic within the study period.Main outcome measureThe primary outcome was the capacity of families to make out-of-pocket payment (CTP) for treatment.ResultsThis study enrolled 84 respondents, with CHE analysis based on 83 participants with complete income data. The approximate combined family monthly income of 77.4% was below ₦300,000(∼$222), supporting a median of five family members. A single government-subsidized surgical intervention can cost as much as ₦600,000(∼$444) out-of-pocket. Applying the WHO threshold of out-of-pocket expenditure exceeding 40% of household's capacity to pay(CTP), and using phenotype-specific cost pathways, an estimated 53.0% to 59.0% of families would face CHE from direct treatment costs, with no statistically significant difference across cleft phenotypes. For unilateral and bilateral cleft lip and palate, the 10-year direct cost of comprehensive cleft care at our center ranges from ₦2,975,000 to ₦3,980,000 (∼$2204-$2948), which exceeds the total annual income of many participating families.ConclusionThe result of this study reveals the frailty of the current healthcare financing model for orofacial cleft management in Nigeria and the urgent need for policy intervention to extend insurance coverage to the full multidisciplinary care pathway.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Preventive Healthcare Services
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
